Ligand-exchangeability of 2-coordinate phosphinegold(I) complexes with AuSP and AuNP cores showing selective antimicrobial activities against Gram-positive bacteria. Crystal structures of [Au(2-Hmpa)(PPh3)] and [Au(6-Hmna)(PPh3)] (2-H2mpa=2-mercaptopropionic acid, 6-H2mna=6-mercaptonicotinic acid)

Journal of Inorganic Biochemistry

Volumn 95, Issue 2-3, 2003, Pages 208-220

  Nomiya, Kenji ^a   Yamamoto, Satoshi ^a   Noguchi, Ryusuke ^a   Yokoyama, Hironari ^a   Kasuga, Noriko Chikaraishi ^a   Ohyama, Kei ^a   Kato, Chieko ^a  

^a KANAGAWA UNIVERSITY   (Japan)

Author keywords

2 Mercaptopropionic acid; 6 Mercaptonicotinic acid; Antimicrobial activities against Gram positive bacteria; Gold(I) complexes; Ligand exchangeability; X ray crystal structures

Indexed keywords

ANION; CYSTEINE; GOLD COMPLEX; PHOSPHINEGOLD; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG STRUCTURE; GRAM POSITIVE BACTERIUM; ION EXCHANGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

POSIBACTERIA;

EID: 0037900137     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00125-9     Document Type: Article

References (53)

1. Kaim W., Schwederski B. Bioinorganic Chemistry: Inorganic Elements in the Chemistry of Life. 1994;373 Wiley, New York.
2. Abrams M.J., Murrer B.A. Science. 261:1993;725.
3. Shaw C.F. III. Chem. Rev. 99:1999;2589.
4. Elder R.C., Eidsness M.K. Chem. Rev. 87:1987;1027.
5. Brown D.H., Smith W.E. Chem. Soc. Rev. 3:1980;217.
6. Shaw C.F. III. Inorg. Perspect. Biol. Med. 2:1978;287.
7. Sadler P.J. Struct. Bond. (Berlin). 29:1976;171.
8. Shaw C.F. III. Farrell N.P. Uses of Inorganic Chemistry in Medicine. 1999;26 RSC.
9. H. Veen, A.A.M. Kwakkenbos, Sci. Hortic. (Amsterdam) 18 (1982, 1983) 277.
10. Veen H. Sci. Hortic. (Amsterdam). 20:1983;211.
11. Thurman R.B., Gerba C.P. CRC Crit. Rev. Environ. Contr. 18:1989;295.
12. Davies K.M., Hobson G.E., Grierson D. Plant. Cell Environ. 11:1988;729.
13. Lopez-Garzon R., Romero-Molina M.A., Navarrete-Guijosa A., Lopez-Gonzalez J.M., Alvarez-Cienfuegos G., Herrador-Pino M.M. J. Inorg. Biochem. 38:1990;139.
14. Bau R. J. Am. Chem. Soc. 120:1998;9380.
15. H.E. Howard-Lock, D.J. LeBlanc, C.J.L. Lock, R.W. Smith, Z. Wang, J. Chem. Soc., Chem. Commun. (1996) 1391.
16. Rhodes M.D., Sadler P.J., Scawen M.D., Silver S. J. Inorg. Biochem. 46:1992;129.
17. S.M. Cottrill, H.L. Sharma, D.B. Dyson, R.V. Parish, C.A. McAuliffe, J. Chem. Soc., Perkin II (1989) 53.
18. Corey E.J., Mehrotra M., Khan A.U. Science. 236:1987;68.
19. Bryan D.L.B., Mikuriya Y., Hempel J.C., Mellinger D., Hashim M., Pasternack R.F. Inorg. Chem. 26:1987;4180.
20. Mirabelli C.K., Johnson R.K., Hill D.T., Faucette L.F., Girard G.R., Kuo G.Y., Sung C.M., Crooke S.T. J. Med. Chem. 29:1986;218.
21. Chan M.K., Minta J.O. Immunopharmacology. 10:1985;61.
22. M.T. Razi, P.J. Sadler, D.T. Hill, B.M. Sutton, J. Chem. Soc., Dalton Trans. (1983) 1331.
23. Elder R.C., Ludwig K., Cooper J.N., Eidsness M.K. J. Am. Chem. Soc. 107:1985;5024.
24. Parish R.V. Interdisciplinary Sci. Rev. 17:1992;221.
25. Sue R.J., Sadler P.J. Metal-Based Drugs. 1:1994;107.
26. de Vos D., Clements P., Pyke S.M., Smyth D.R., Tiekink E.R.T. Metal-Based Drugs. 6:1999;31.
27. McKeage M.J., Papathanasiou P., Salem G., Sjaarda A., Swiegers G.F., Waring P., Wild S.B. Metal-Based Drugs. 5:1998;217.
28. Nomiya K., Noguchi R., Ohsawa K., Tsuda K., Oda M. J. Inorg. Biochem. 78:2000;363.
29. K. Nomiya, S. Takahashi, R. Noguchi, J. Chem. Soc. Dalton Trans. (2000) 2091.
30. Nomiya K., Noguchi R., Shigeta T., Kondoh Y., Tsuda K., Ohsawa K., Kasuga N.C., Oda M. Bull. Chem. Soc. Jpn. 73:2000;1143.
31. K. Nomiya, K. Tsuda, N.C. Kasuga, J. Chem. Soc., Dalton Trans. (1998) 1653.
32. Nomiya K., Tsuda K., Tanabe Y., Nagano H. J. Inorg. Biochem. 69:1998;9.
33. Nomiya K., Tsuda K., Sudoh T., Oda M. J. Inorg. Biochem. 68:1997;39.
34. Nomiya K., Noguchi R., Oda M. Inorg. Chim. Acta. 298:2000;24.
35. K. Nomiya, H. Yokoyama, J. Chem. Soc. Dalton Trans. (2002) 2483.
36. Ahmad S., Isab A.A. J. Inorg. Biochem. 88:2002;44.
37. Isab A.A. J. Inorg. Biochem. 88:2002;53.
38. Novelli F., Recine M., Sparatore F., Juliano C. Il Farmaco. 54:1999;232.
39. Fricker S.P. Gold Bull. 29:1996;53.
40. Elsome A.M., Hamilton-Miller J.M.T., Brumfitt W., Noble W.C. J. Antimicrob. Chemother. 37:1996;911.
41. Berners-Price S.J., Johnson R.K., Giovenella A.J., Faucette L.F., Mirabelli C.K., Sadler P.J. J. Inorg. Biochem. 33:1988;285.
42. Howe B.P., Parish R.V., Pritchard R.G. Quim. Nova. 21:1998;564.
43. de Athayde Filho P.F., Howe B.P., Miller J. Metal-Based Drugs. 7:2000;55.
44. Nomiya K., Kasuga N.C., Takamori I., Tsuda K. Polyhedron. 17:1998;3519.
45. Smyth D.R., Vincent B.R., Tiekink E.R.T. Z. Kristallogr. 216:2001;298.
46. J.D.E.T. Wilton-Ely, A. Schier, N.W. Mitzel, H. Schmidbaur, J. Chem. Soc., Dalton Trans. (2001) 1058.
47. Bruce M.I., Nicholson B.K., Shawkataly O.B. Inorg. Synth. 26:1989;324.
48. Baenziger N.C., Bennett W.E., Soboroff D.M. Acta Crystallogr. B32:1976;962.
49. Goodgame D.M.L., O'Mahoney C.A., Plank S.D., Williams D.J. Polyhedron. 12:1993;2705.
50. H.(Y.) Okuno, T. Tomohiro, M.-T. Younou, J. Chem. Soc. Dalton Trans. (1990) 3375.
51. Tagawa H., Ueno K. Chem. Pharm. Bull. 26:1978;1384.
52. K. Nomiya, R. Noguchi, K. Ohsawa, K. Tsuda, J. Chem. Soc., Dalton Trans. (1998) 4101.
53. TEXSAN: Crystal Structure Analysis Package, Molecular Structure Corporation, Houston, TX, 1985 and 1992.